ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions. See why SPRY stock is a Buy.

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...

Obesity drug maker Novo Nordisk forecast slower growth this year after Wegovy sales more than doubled in the final quarter of ...

Federal lawmakers are trying once again to push for a study on the “overmedication” of veterans by Department of Veterans ...

Agents from the Drug Enforcement Administration conducted an on-site audit of beagle breeder Ridglan Farms Wednesday, the federal agency confirmed.

Lawyers claim Johnson & Johnson knew that the product contained cancer causing asbestos, but failed to warn customers and ...

We recently compiled a list of the 10 Best Foreign Stocks With Dividends For Passive Income. In this article, we are going to ...

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

MoneyShow presents top investment ideas for 2024 from leading advisors. Part 8 includes Lara Exploration, Imperial Oil, Avino ...

Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set of results.

The Union Budget 2025 has waived import duty on 36 life-saving drugs and reduced it for six others. While this is expected to ...

Washington State University scientists have created genetically-engineered mice that could help accelerate anti-aging ...